Skip to main content
Erschienen in: Strahlentherapie und Onkologie 6/2016

14.03.2016 | Original Article

IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma

Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06)

verfasst von: Dr. Sung Ho Moon, M.D., Dr. Kwan Ho Cho, M.D., Dr. Chang-Geol Lee, M.D., Dr. Ki Chang Keum, M.D., Dr. Yeon-Sil Kim, M.D., Dr. Hong-Gyun Wu, M.D., Dr. Jin Ho Kim, M.D., Dr. Yong Chan Ahn, M.D., Dr. Dongryul Oh, M.D., Dr. Jong Hoon Lee, M.D.

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective

We compared treatment outcomes of two-dimensional radiotherapy (2D-RT), three-dimensional conformal radiotherapy (3D-CRT), and intensity-modulated radiotherapy (IMRT) in patients with nasopharyngeal carcinoma (NPC).

Patients and methods

In total, 1237 patients with cT1-4N0-3M0 NPC were retrospectively analyzed. Of these, 350, 390, and 497 were treated with 2D-RT, 3D-CRT, and IMRT, respectively.

Results

3D-CRT and IMRT showed better 5-year overall survival (OS) rates (73.6 and 76.7 %, respectively) than did 2D-RT (5-year OS of 59.7 %, all p < 0.001). In T3–4 subgroup, IMRT was associated with a significantly better 5-year OS than was 2D-RT (70.7 vs. 50.4 %, respectively; p ≤ 0.001) and 3D-CRT (70.7 vs. 57.8 %, respectively; p = 0.011); however, the difference between the 2D-RT and 3D-CRT groups did not reach statistical significance (p = 0.063). In multivariate analyses of all patients, IMRT was a predictive factor for OS when compared with 2D-RT or 3D-CRT, as was 3D-CRT when compared with 2D-RT.

Conclusion

Our study showed that 3D-CRT and IMRT were associated with a better local progression-free survival and OS than was 2D-RT in NPC. IMRT was significantly superior in terms of OS for advanced primary tumors (T3–4).
Literatur
1.
Zurück zum Zitat Al-Sarraf M, LeBlanc M, Giri PG et al (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16:1310–1317PubMed Al-Sarraf M, LeBlanc M, Giri PG et al (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16:1310–1317PubMed
2.
3.
Zurück zum Zitat Chan AT, Leung SF, Ngan RK et al (2005) Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 97:536–539. doi:10.1093/jnci/dji084 CrossRefPubMed Chan AT, Leung SF, Ngan RK et al (2005) Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 97:536–539. doi:10.​1093/​jnci/​dji084 CrossRefPubMed
4.
Zurück zum Zitat Chen L, Hu CS, Chen XZ et al (2012) Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol 13:163–171. doi:10.1016/S1470-2045(11)70320-5 CrossRefPubMed Chen L, Hu CS, Chen XZ et al (2012) Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol 13:163–171. doi:10.​1016/​S1470-2045(11)70320-5 CrossRefPubMed
7.
Zurück zum Zitat Lee AW, Tung SY, Chua DT et al (2010) Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 102:1188–1198. doi:10.1093/jnci/djq258 CrossRefPubMed Lee AW, Tung SY, Chua DT et al (2010) Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 102:1188–1198. doi:10.​1093/​jnci/​djq258 CrossRefPubMed
8.
Zurück zum Zitat Wee J, Tan EH, Tai BC et al (2005) Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23:6730–6738. doi:10.1200/JCO.2005.16.790 CrossRefPubMed Wee J, Tan EH, Tai BC et al (2005) Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23:6730–6738. doi:10.​1200/​JCO.​2005.​16.​790 CrossRefPubMed
10.
11.
Zurück zum Zitat Pow EH, Kwong DL, McMillan AS et al (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66:981–991. doi:10.1016/j.ijrobp.2006.06.013 CrossRefPubMed Pow EH, Kwong DL, McMillan AS et al (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66:981–991. doi:10.​1016/​j.​ijrobp.​2006.​06.​013 CrossRefPubMed
12.
Zurück zum Zitat Lee N, Xia P, Quivey JM et al (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53:12–22CrossRefPubMed Lee N, Xia P, Quivey JM et al (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53:12–22CrossRefPubMed
13.
Zurück zum Zitat Fang FM, Chien CY, Tsai WL et al (2008) Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study. Int J Radiat Oncol Biol Phys 72:356–364. doi:10.1016/j.ijrobp.2007.12.054 CrossRefPubMed Fang FM, Chien CY, Tsai WL et al (2008) Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study. Int J Radiat Oncol Biol Phys 72:356–364. doi:10.​1016/​j.​ijrobp.​2007.​12.​054 CrossRefPubMed
14.
Zurück zum Zitat Lai SZ, Li WF, Chen L et al (2011) How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 80:661–668. doi:10.1016/j.ijrobp.2010.03.024 CrossRefPubMed Lai SZ, Li WF, Chen L et al (2011) How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 80:661–668. doi:10.​1016/​j.​ijrobp.​2010.​03.​024 CrossRefPubMed
16.
Zurück zum Zitat Peng G, Wang T, Yang KY et al (2012) A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol 10486–293. doi:10.1016/j.radonc.2012.08.013 CrossRef Peng G, Wang T, Yang KY et al (2012) A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol 10486–293. doi:10.​1016/​j.​radonc.​2012.​08.​013 CrossRef
18.
Zurück zum Zitat Lee AW, Lau WH, Tung SY et al (2005) Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23:6966–6975. doi:10.1200/JCO.2004.00.7542 CrossRefPubMed Lee AW, Lau WH, Tung SY et al (2005) Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23:6966–6975. doi:10.​1200/​JCO.​2004.​00.​7542 CrossRefPubMed
19.
Zurück zum Zitat Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346. doi:10.1016/0360-3016(95)00060-C CrossRefPubMed Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346. doi:10.​1016/​0360-3016(95)00060-C CrossRefPubMed
20.
Zurück zum Zitat Jen YM, Shih R, Lin YS et al (2005) Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy. Radiother Oncol 75:204–209. doi:10.1016/j.radonc.2005.03.005 CrossRefPubMed Jen YM, Shih R, Lin YS et al (2005) Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy. Radiother Oncol 75:204–209. doi:10.​1016/​j.​radonc.​2005.​03.​005 CrossRefPubMed
23.
Zurück zum Zitat Cheng SH, Yen KL, Jian JJ et al (2001) Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. Int J Radiat Oncol Biol Phys 50:717–726CrossRefPubMed Cheng SH, Yen KL, Jian JJ et al (2001) Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. Int J Radiat Oncol Biol Phys 50:717–726CrossRefPubMed
24.
Zurück zum Zitat Ou SH, Zell JA, Ziogas A, Anton-Culver H (2005) Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol 18:29–35. doi:10.1093/annonc/mdl320 CrossRef Ou SH, Zell JA, Ziogas A, Anton-Culver H (2005) Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol 18:29–35. doi:10.​1093/​annonc/​mdl320 CrossRef
Metadaten
Titel
IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma
Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06)
verfasst von
Dr. Sung Ho Moon, M.D.
Dr. Kwan Ho Cho, M.D.
Dr. Chang-Geol Lee, M.D.
Dr. Ki Chang Keum, M.D.
Dr. Yeon-Sil Kim, M.D.
Dr. Hong-Gyun Wu, M.D.
Dr. Jin Ho Kim, M.D.
Dr. Yong Chan Ahn, M.D.
Dr. Dongryul Oh, M.D.
Dr. Jong Hoon Lee, M.D.
Publikationsdatum
14.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 6/2016
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-016-0959-y

Weitere Artikel der Ausgabe 6/2016

Strahlentherapie und Onkologie 6/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.